Skip to main content
. Author manuscript; available in PMC: 2010 Jan 1.
Published in final edited form as: Wound Repair Regen. 2009;17(1):1–18. doi: 10.1111/j.1524-475X.2008.00436.x

Table 1.

HIF-1 target genes

Erythropoiesis/
Iron
Metabolism
Cell
Survival/
Proliferation
Angiogenesis Vascular
tone
Glucose
Metabolism
Matrix
Metabolism
EPO IGF2 VEGF NOS2 HK1,2 MMPs
Tf TGF-α Leptin HO1 LDHA PAR/PAI
Tfr ADM TGF-▯3 ET1 PKM Coll PHD
Ceruloplasmin BNip3 EG-VEGF ADM PFKL
NIX α1b PGK1
NDRG2 PFKFB3
GAPDH
GLUT1,3
ENO1
CA-9
ALD-A,C
AK-3

α1b, α1b-adrenergic receptor; ADM, adrenomedulin; AK, adenylate kinase; ALD, aldolase; BNip3, Bcl-2/adenovirus EIB 19kD-interacting protein 3; CA, carbonic anhydrase; Coll PHD, collagen prolylhydroxylases; EG-VEGF, endocrine gland-derived VEGF; ENO, enolase; EPO, erythropoietin; ET, endothelin; GAPDH, gylceraldehyde phosphate dehydrogenase; GLUT, glucose transporters; HK1,2, hexokinase 1,2; HO, heme oxygenase; IGF, insulin-like growth factor; LDH-A, lactate dehydrogenase-A; MMP, matrix metalloproteinases; NDRG, N-Myc downstream-regulated genes; NIX, Nip 3-like protein X; NOS, nitric oxide synthase; PAR/PAI, plasminogen activator receptors and inhibitors; PGK1, phosphoglycerate kinase 1; PFKL, phosphofructokinase L; PKM, pyruvate kinase M; TGF, transforming growth factor; TF, transferrin; Tfr, Tf receptor.